Pharmacology News

Cancer centers in the United States continue to experience critical shortages of commonly used platinum-based chemotherapies, according to survey results from National Comprehensive Cancer Network.

Antimicrobial stewardship interventions recommended by either female or male clinicians were equally accepted, according to a recent study.

A study of almost 4,000 people with HIV and sustained 2-year period of viral suppression found that they were unlikely to experience viral rebound over the next 2 years, supporting treatment as prevention as an HIV prevention strategy.

Amid an ongoing drug shortage, the FDA is allowing the chemotherapy drug cisplatin to be imported from China.

There has been a landscape of litigation to hold responsible parties accountable for their part in the opioid crisis.

The FDA has proposed a rule that would require patients to receive an easy-to-read medication information guide when they are prescribed drugs and certain biological products, the agency announced in a press release.

About 58% of pharmacies reported availability of buprenorphine for opioid use disorder at the time of patients’ requests, according to researchers.

Physicians listen to the patient in front of us. We care for one patient at a time. There is inherent individualization in the patient interaction. Each story is unique. Each treatment plan is tailored.

Development and use of oral chemotherapy medications has increased substantially over the past decade, offering many patients with cancer a more convenient and less stressful treatment option.

As president of Association of Community Cancer Centers, Olalekan Ajayi, PharmD, MBA, is heeding the lessons of the COVID-19 pandemic.